NDC 55154-6777

XIFAXAN

Rifaximin

XIFAXAN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Rifaximin.

Product ID55154-6777_08ea4212-5126-48c4-8cb5-3ec2f57601ba
NDC55154-6777
Product TypeHuman Prescription Drug
Proprietary NameXIFAXAN
Generic NameRifaximin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2010-05-01
Marketing CategoryNDA / NDA
Application NumberNDA021361
Labeler NameCardinal Health
Substance NameRIFAXIMIN
Active Ingredient Strength550 mg/1
Pharm ClassesRifamycin Antibacterial [EPC],Rifamycins [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 55154-6777-8

360 TABLET in 1 BOTTLE, PLASTIC (55154-6777-8)
Marketing Start Date2010-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55154-6777-8 [55154677708]

XIFAXAN TABLET
Marketing CategoryNDA
Application NumberNDA021361
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-05-01

Drug Details

Active Ingredients

IngredientStrength
RIFAXIMIN550 mg/1

Pharmacological Class

  • Rifamycin Antibacterial [EPC]
  • Rifamycins [CS]

NDC Crossover Matching brand name "XIFAXAN" or generic name "Rifaximin"

NDCBrand NameGeneric Name
50090-2445XIFAXANrifaximin
55154-6777XIFAXANrifaximin
65649-301XIFAXANrifaximin
65649-303XIFAXANrifaximin
68151-4980XIFAXANrifaximin
68258-1107XIFAXANRIFAXIMIN
69189-0309XIFAXANrifaximin

Trademark Results [XIFAXAN]

Mark Image

Registration | Serial
Company
Trademark
Application Date
XIFAXAN
XIFAXAN
78428755 2965332 Live/Registered
ALFASIGMA S.P.A.
2004-06-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.